Does cimetidine improve prospects for cancer patients? A reappraisal of the evidence to date

Digestion

Volumn 60, Issue 5, 1999, Pages 415-421

  Siegers, Claus Peter ^a   Andresen, S ^b   Keogh, J P ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

Cimetidine; Colorectal cancer; Gastric cancer; H2 receptor; Histamine

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE; RANITIDINE;

ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; DRUG MECHANISM; HUMAN; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STOMACH CANCER; SUPPRESSOR CELL; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANTINEOPLASTIC AGENTS; CARCINOMA, RENAL CELL; CIMETIDINE; GASTROINTESTINAL NEOPLASMS; HISTAMINE H2 ANTAGONISTS; HUMANS; KIDNEY NEOPLASMS; MELANOMA; T-LYMPHOCYTES, REGULATORY;

EID: 0032806998     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007686     Document Type: Review

References (34)

1. Moller H, Lindvig K, Klefter R, Mosbech J, Moller Jensen O: Cancer occurrence in a cohort of patients treated with cimetidine. Gut 1989; 30:1558-1562.
2. Correa, P: A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-3560.
3. 2-receptor antagonist tiotidine. Scand J Gastroenterol Suppl 1984;101:109-117.
4. Moller H, Nissen A, Mosbech J: Use of cimetidine and other peptic ulcer drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. Gut 1992;33: 1166-1169.
5. 2 histaminics (ranitidine or cimetidine). Eur J Cancer Clin Oncol 1988;21:161-167.
6. Tonnesen H, Knigge UP, Bulow S, Damm P, Fischerman K, Hesselfeldt P, Hjortrup A: Cimetidine treatment of stomach cancer. Ugeskr Læger 1989;151:1549-1551.
7. Taylor TV et al: Healing of a malignant gastric ulcer with cimetidine. J R Coll Surg Edinb 1988;33:339-340.
8. Adams WJ, Morris DL: Short-course cimetidine and survival with colorectal cancer. Lancet 1994;1344:1768-1769.
9. Matsumoto S: Cimetidine and survival with colorectal cancer. Lancet 1995;346:115.
10. Links M, Clingan PR, Phadke K, O'Baugh J, Legge J, Adams WJ, Ross WB, Morris DL: A randomized trial of cimetidine with 5-fluorouracil and folinic acid in metastatic colorectal cancer. Eur J Surg Oncol 1995;21:523-525.
11. Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graversen P, Kjærgard J, Luke M, Stimpel H, Sparso BH: Cimetidine as an adjuvant treatment in colorectal cancer. A double-blind, randomized pilot study. Dis Colon Rectum 1995; 38:514-518.
12. Primrose JN, Miller GV, Preston SR, Gokhale J, Ambrose NS, Ward UM, Mills JG, Ebsanullah RSB, Darekar B: A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer. Gut 1998;42:17-19.
13. Adams WJ, Lawson JA, Nicholson SE, Cook TA, Morris DL: The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur J Surg Oncol 1993;19:332-335.
14. Adams WJ, Lawson JA, Morris DL: Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994;35:1632-1636.
15. Lawson JA, Adams WJ, Morris DL: Ranitidine and cimetidine differ in their in vitro and in vivo effects on human colonic cancer growth. Br J Cancer 1993;73:872-876.
16. Watson SA, Wilkinson LJ, Robertson JFR, Hardcastle JD: Effect of histamine on the growth of human gastrointestinal tumours: Reversal by cimetidine. Gut 1993;34:1091-1096.
17. Morris DL, Adams WJ: Cimetidine and colorectal cancer - old drug, new use. Nat Med 1995;1:1243-1244.
18. Garcia-Cabellero M, Nunezed X, Castro I, Kusche J, Vora Thorbeck L: Histamine metabolism in human breast and colorectal cancer: Its effects on other host tissues. Adv Biosci 1993;89:273-287.
19. Jeziorska M, Haboubi NY, Schofield PF, Wooley DE: Mast cell distribution and tumour cell proliferation in colonic carcinoma. Gut 1993; 34:55.
20. 125I]iodoaminopotentidine. J Neurochem 1992;59: 290-299.
21. Nanda NK, Nath I: Characteristics of histamine receptors present on suppressor T cells in 'healthy individuals'. Scand J Gastroenterol 1995;30:265-271.
22. Siegers CP, Hiltl DM, Stich R: Cimetidine hemmt das Tumorzellwachstum, Therapiewoche 1995;36:2110-2114.
23. Hahm KB, Park IS, Kim HC, Lee KJ, Kim JH, Cho SW, Lee SI: Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells. Int J Immunopharmacol 1996;18:393-399.
24. Hahm KB, Kim WH, Lee SI, Kang JK, Park IS: Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. Int J Immunopharmacol 1994;16:985-993.
25. Wen QS, Zhang GZ, Kong XT: Modulation effect of cimetidine on the production of IL-2 and interferon-gamma in patients with gastric cancer. Leukemia 1994;8:(suppl):121-126.
26. Adams WJ, Morris DL: Pilot study - cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: Results of a small randomized control trial. 1997;80:15-21.
27. Hansbrough J, Zapata-Sirvent R, Bender E: Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg 1986;151:249-255.
28. Smith T: Histamine type 2 receptor antagonists and cancer immunotherapy. Compr Ther 1990;16:8-13.
29. Flodgren P, Borgström S, Jonsson PE, Lindström C, Sjögren HO: Metastatic malignant melanoma: Regression induced by combined treatment with interferon [HulFN-alpha(Le)] and cimetidine. Int J Cancer 1983;32:657-665.
30. Creagan ET, Schaid DJ, Ahmann DL, Frytak S: Disseminated malignant melanoma and recombinant interferon: Analysis of seven consecutive phase II investigations. J Invest Dermatol 1990;95(suppl):188-192.
31. Marshall ME, Mendelsohn L, Butler K, Riley L, Cantrell J, Wiseman C, Taylor R, Macdonald JS: Treatment of metastatic renal cell carcinoma with coumarin (1,2-benzopyrone) and cimetidine: A pilot study. J Clin Oncol 1987;5: 862-866.
32. Kinouchi T, Saiki S, Maeda O, Kuroda M, Usami M, Kotake T: Treatment of advanced renal cell carcinoma with a combination of human lymphoblastoid interferon-alpha and cimetidine. J Urol 1997;157:1604-1607.
33. Sagaster P, Micksche M, Flamm J, Ludwig H: Randomised study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer. Ann Oncol 1995;6:999-1003.
34. Inhorn L, Williams SD, Nattam S, Stephens D: High-dose cimetidine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group study. Am J Clin Oncol 1992;15: 157-159.